DavidFSciortinoMD

PubMed

• 11 citations
  Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
  Nicholas W. Choong, Ann M. Mauer, Daniel Haraf, Mark K. Ferguson, Alan Sandler, Kenneth A. Kesler, Paul A. S. Fishkin, Rafat Ansari, James L. Wade, Stuart A. Krauss, D...> ;Medical Oncology. 2011 Dec 1
• 19 citations
  Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer
  Nicholas W. Choong, Ann M. Mauer, Philip C. Hoffman, Charles M. Rudin, Jerome D. Winegarden, J. Lee Villano, Mark Kozloff, James L. Wade, David F. Sciortino, Livia Sze...> ;Journal of Thoracic Oncology. 2006 Mar 1
• 23 citations
  Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma
  Sridhar Mani, David F. Sciortino, Brian L. Samuels, Rose Arrietta, Richard L. Schilsky, Everett E. Vokes, Steven E. Benner> ;Investigational New Drugs. 1999 Jan 1
• 13 citations
  Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma
  Sridhar Mani, Thomas D. Schiano, Juan C. Garcia, Rafat Ansari, Brian L. Samuels, David F. Sciortino, Shrunali Tembe, Keith L. Shulman, Alfred L. Baker, Steven E. Benne...> ;Investigational New Drugs. 1998 Dec 1
• 29 citations
  Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer
  Sridhar Mani, John W. Kugler, James A. Knost, David F. Sciortino, Joseph Gibbons, Juan C. Garcia, Rafat Ansari, Richard L. Schilsky, Everett E. Vokes> ;Investigational New Drugs. 1998 Jan 1
• 15 citations
  Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: A University of Chicago phase II consortium study
  Sridhar Mani, John W. Kugler, David F. Sciortino, Juan C. Garcia, Rafat Ansari, Rod A. Humerickhouse, Fabrizio Michelassi, Mitchell C. Posner, K. L. Shulman, Richard L...> ;Annals of Oncology. 1998 Sep 1
• A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
  Vokes, E. E., Ansari, R. H., Masters, G. A., Hoffman, P. C., Klepsch, A., Ratain, M. J., Sciortino, D. F., Lad, T. E., Krauss, S., Fishkin, P. A., Golomb, H. M.> ;Ann Oncol. 1998 Oct
• Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial.
  Sonpavde, G., Ansari, R., Walker, P., Sciortino, D. F., Gabrys, G. T., Murdock, A., Gonin, R., Einhorn, L. H.> ;Am J Clin Oncol. 2000 Feb
• Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.
  Lad, T., Rosen, F., Sciortino, D., Brockstein, B., Keubler, J. P., Arietta, R., Vokes, E.> ;Invest New Drugs. 2000 Aug
• Join now to see all